A Study of Experimental HM15211 Treatment in NASH
Summary
- Eligibility
- for people ages 18-70 (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Souvik Sarkar
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Davis
- Souvik Sarkar
Assistant Professor, Gastroenterology and Hepatology, School of Medicine. Authored (or co-authored) 48 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Links
- Sign up for this study
- ID
- NCT04505436
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 217 study participants
- Last Updated